Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001829126-25-005721
Filing Date
2025-08-04
Accepted
2025-08-01 21:23:07
Documents
8

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 5125620
2 GRAPHIC img_001a.jpg GRAPHIC 18921
3 GRAPHIC img_001.jpg GRAPHIC 53692
4 GRAPHIC img_002a.jpg GRAPHIC 7930
5 GRAPHIC img_003.jpg GRAPHIC 12985
6 GRAPHIC img_004.jpg GRAPHIC 21918
7 GRAPHIC img_005.jpg GRAPHIC 63700
8 GRAPHIC img_006.jpg GRAPHIC 33572
  Complete submission text file 0001829126-25-005721.txt   5417705
Mailing Address 207 S. SANTA ANITA STREET, SUITE P-15 SAN GABRIEL CA 91776
Business Address 207 S. SANTA ANITA STREET, SUITE P-15 SAN GABRIEL CA 91776 (626) 400-6603
Vesicor Therapeutics, Inc. (Filer) CIK: 0001993074 (see all company filings)

EIN.: 262470586 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-08098-01 | Film No.: 251177792

Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: DRS/A | Act: 33 | File No.: 377-08098 | Film No.: 251177791
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)